Early effects of tumour necrosis factor α blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis

Background: Tumour necrosis factor α (TNFα) blockade using infliximab, a chimeric anti-TNFα antibody, is an effective treatment for both psoriasis and psoriatic arthritis (PsA). Objective: To analyse the early effects of infliximab treatment on serial skin and synovial tissue biopsy samples. Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Goedkoop, A, Kraan, M, Teunissen, M, Picavet, D, de Rie, M A, Bos, J, Tak, P
Format: Artigo
Language:Inglês
Published: 2004
Subjects:
Extended Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755073/
https://ncbi.nlm.nih.gov/pubmed/15194570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.018085
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items